Eli Lilly’s Alopecia Drug Shows Strong Phase 3 Results; Senator Rubio Addresses Gaza Future and UNRWA

Key TakeawaysEli Lilly's (LLY) Baricitinib (Olumiant) demonstrated significant scalp hair regrowth in over 50% of adolescents with severe alopecia areata in a Phase 3 trial, with continuous improvements observed through 52 weeks and no new safety concerns.Senator Marco Rubio stated that the UNRWA has become a "subsidiary of Hamas" and will not play a role in future humanitarian aid efforts in Gaza, citing concerns over its neutrality.Rubio emphasized that Hamas must fully demilitarize and will not be part o ...